Yalowich J C
Cancer Res. 1987 Feb 15;47(4):1010-5.
The effects of microtubule inhibitors on cellular accumulation of 4'-demethylepipodophyllotoxin-9-(4,6-O-ethylidine-beta-D-glu copyranoside) (VP-16) and subsequent epipodophyllotoxin-induced DNA single-strand breaks were investigated in human leukemia K562 cells. At concentrations of 0.05-20 microM, vinblastine, vincristine, and maytansine similarly increased the steady-state cell concentration of VP-16 (2.5 microM) up to 2-fold. Following removal of extracellular vinblastine, the elevation of cell VP-16 was maintained through an additional 55-min incubation period. Washing cells free of extracellular VP-16 resulted in a nonexchangeable (or bound) component comprising 15-17% of the VP-16 concentration found before removal of extracellular drug. In cells incubated with VP-16 alone, removal of extracellular drug resulted in less than 5% cell retention of drug. At vinblastine concentrations of 0.05-0.2 microM, the increase in cell VP-16 was due to a progressive increase in nonexchangeable VP-16. At greater vinblastine concentrations, up to 10 microM, there was no further increase in nonexchangeable VP-16 but there was a 1.6-fold increase in the exchangeable (or free) concentration of VP-16. Similar elevation of both nonexchangeable and exchangeable VP-16 by 10 microM vincristine and maytansine was observed; however, 50-100 microM podophyllotoxin or taxol was required for comparable elevation of exchangeable drug with no increase of nonexchangeable VP-16. Elevation of exchangeable VP-16 in the presence of vinblastine was due to inhibition of the unidirectional efflux of this epipodophyllotoxin with a 69% decline in the rate constant for efflux. There were no effects of vinblastine on VP-16 influx. There was no enhancement of DNA single-strand break frequency when cells were incubated with 2.5 microM VP-16 and 0.2 microM vinblastine, a concentration of the Vinca alkaloid that increased only nonexchangeable VP-16. VP-16-induced DNA damage was enhanced by vinblastine concentrations above 0.5 microM, concentrations that elevated exchangeable VP-16, with a maximum doubling of radiation equivalent single-strand break frequency observed with 20 microM vinblastine, consistent with the maximum elevation of cell VP-16 with 20 microM Vinca alkaloid. These results indicate that vinblastine and other microtubule inhibitors elevate cell VP-16 by inhibition of the efflux of exchangeable drug and by increasing the level of nonexchangeable drug. Potentiation of VP-16-induced DNA damage is observed only at microtubule inhibitor concentrations which elevate exchangeable VP-16.(ABSTRACT TRUNCATED AT 400 WORDS)
在人白血病K562细胞中研究了微管抑制剂对4'-去甲基表鬼臼毒素-9-(4,6-O-亚乙基-β-D-吡喃葡萄糖苷)(VP-16)细胞蓄积及随后表鬼臼毒素诱导的DNA单链断裂的影响。长春碱、长春新碱和美登素在0.05 - 20微摩尔浓度下,同样可使VP-16(2.5微摩尔)的稳态细胞浓度增加至2倍。去除细胞外长春碱后,细胞VP-16水平在额外的55分钟孵育期内仍维持升高。将细胞洗涤去除细胞外VP-16后,会产生一种不可交换(或结合)成分,其占去除细胞外药物前VP-16浓度的15 - 17%。在仅用VP-16孵育的细胞中,去除细胞外药物后,药物在细胞中的保留率不到5%。在长春碱浓度为0.05 - 0.2微摩尔时,细胞VP-16的增加是由于不可交换VP-16的逐渐增加。在更高的长春碱浓度下,高达10微摩尔,不可交换VP-16没有进一步增加,但VP-16的可交换(或游离)浓度增加了1.6倍。观察到10微摩尔长春新碱和美登素同样使不可交换和可交换VP-16升高;然而,需要50 - 100微摩尔鬼臼毒素或紫杉醇才能使可交换药物有类似升高,且不可交换VP-16没有增加。长春碱存在时可交换VP-16的升高是由于抑制了这种表鬼臼毒素的单向流出,流出速率常数下降了69%。长春碱对VP-16流入没有影响。当细胞用2.5微摩尔VP-16和0.2微摩尔长春碱孵育时,DNA单链断裂频率没有增加,0.2微摩尔的长春花生物碱仅增加不可交换VP-16。高于0.5微摩尔的长春碱浓度可增强VP- l6诱导的DNA损伤,该浓度可升高可交换VP-16,在20微摩尔长春碱时观察到辐射当量单链断裂频率最大增加一倍,这与20微摩尔长春花生物碱使细胞VP-16最大升高一致。这些结果表明,长春碱和其他微管抑制剂通过抑制可交换药物的流出和增加不可交换药物水平来升高细胞VP-16。仅在微管抑制剂浓度升高可交换VP-16时,才观察到VP-16诱导的DNA损伤增强。(摘要截短于400字)